ARRY » Topics » EXHIBIT INDEX

This excerpt taken from the ARRY 8-K filed Feb 1, 2010.

EXHIBIT INDEX


Exhibit No.  
 
99.1

Press release dated February 1, 2010 entitled “Array BioPharma Reports Financial Results for the Second Quarter of Fiscal 2010.”

4

This excerpt taken from the ARRY 8-K filed Nov 3, 2009.

EXHIBIT INDEX

 

Exhibit
No.

 

Description

10.1

 

Description of performance bonus program

 

4


This excerpt taken from the ARRY 8-K filed Nov 2, 2009.

EXHIBIT INDEX


Exhibit No.  
 
99.1

Press release dated November 2, 2009 entitled “ARRAY BIOPHARMA REPORTS FINANCIAL RESULTS FOR THE FIRST QUARTER OF FISCAL 2010.”

4

This excerpt taken from the ARRY 8-K filed Oct 5, 2009.

EXHIBIT INDEX

 

Exhibit 
No.

 

Document

1.1

 

Fifth Amendment to Loan and Security Agreement dated September 30, 2009 between the registrant and Comerica Bank

 

4


 

This excerpt taken from the ARRY 8-K filed Oct 2, 2009.

EXHIBIT INDEX


Exhibit No.  
 
99.1

Press release dated October 1, 2009 entitled "ARRAY BIOPHARMA TO PRESENT CLINICAL RESULTS ON DIABETES DRUG AT EUROPEAN DIABETES MEETING."




4

This excerpt taken from the ARRY 8-K filed Sep 30, 2009.

EXHIBIT INDEX

 

Exhibit
Number

 

Description

 

 

 

10.1

 

Facility Agreement dated May 15, 2009 by and between the registrant and Deerfield Private Design Fund, L.P. and Deerfield Private Design International

 

4


This excerpt taken from the ARRY 8-K filed Sep 24, 2009.

EXHIBIT INDEX

 

Exhibit
Number

 

Description

 

 

 

4.1

 

Form of Warrant to purchase shares of the registrant’s Common Stock issued to Deerfield Private Design Fund, L.P., Deerfield Private Design International, L.P., Deerfield Partners, L.P., Deerfield International Limited

 

4


This excerpt taken from the ARRY 8-K filed Sep 18, 2009.

EXHIBIT INDEX

 

Exhibit
No.

 

Document

1.1

 

Equity Distribution Agreement, dated September  , 2009, by and between the Registrant and Piper Jaffray & Co.

5.1

 

Opinion of Hogan & Hartson LLP regarding the legality of the Shares

23.1

 

Consent of Hogan & Hartson LLP (included in Exhibit 5.1)

99.1

 

Press Release dated September 18, 2009 entitled Array BioPharma Enters Into Equity Distribution Agreement

 

4


This excerpt taken from the ARRY 8-K filed Sep 4, 2009.

EXHIBIT INDEX

 

Exhibit No.

 

 

 

 

 

99.1

 

Press release dated September 3, 2009 entitled “Array BioPharma Announces Top Line Results From Rheumatoid Arthritis Phase 2 Trial.”

 

 

 

99.2

 

Website slides dated September 3, 2009 entitled “ARRY-162-201: A 12-week, Phase 2, Randomized, Double-blind, Multicenter, Placebo Controlled Study to Investigate the Safety, Pharmacokinetics and Efficacy of ARRY-162, Administered Orally Daily in Patients with Active Rheumatoid Arthritis Incompletely Responsive to Methotrexate-Top-Line Results”

 

4


This excerpt taken from the ARRY 8-K filed Aug 10, 2009.

EXHIBIT INDEX

 

Exhibit No.

 

 

 

 

 

99.1

 

Press release dated August 10, 2009 entitled “Array BioPharma Reports Positive Results of its Oral Glucokinase Activator in Type 2 Diabetes Patients.”

 

4


This excerpt taken from the ARRY 8-K filed Jul 15, 2009.

EXHIBIT INDEX

 

Exhibit No.

 

 

 

 

 

99.1

 

Press release dated July 15, 2009 entitled “Array BioPharma Advances Its Lead MEK Inhibitor Into Cancer.”

 

4


This excerpt taken from the ARRY 8-K filed Jul 8, 2009.

EXHIBIT INDEX

 

Exhibit No.

 

 

 

 

 

99.1

 

Press release dated July 8, 2009 entitled “Array BioPharma Announces Top-Line Results in Two Phase 1 Clinical Trials.”

 

4


This excerpt taken from the ARRY 8-K filed Jun 17, 2009.

EXHIBIT INDEX

 

Exhibit 
No.

 

Description

10.1

 

Description of performance bonus program

 


This excerpt taken from the ARRY 8-K filed May 19, 2009.

EXHIBIT INDEX

 

Exhibit
Number

 

Description

 

 

 

99.1

 

Press release entitled “Array BioPharma Receives Additional $40 Million Funding Commitment,” dated May 19, 2009

 

6


This excerpt taken from the ARRY 8-K filed Apr 21, 2009.

EXHIBIT INDEX

 

Exhibit No.

 

 

 

 

 

99.1

 

Press release dated April 21, 2009 entitled “Array BioPharma Presents Initial Data on Novel Class of Chk1 Inhibitors.”

 

4


This excerpt taken from the ARRY 8-K filed Apr 21, 2009.

EXHIBIT INDEX

 

Exhibit No.

 

 

 

 

 

99.1

 

Press release dated April 21, 2009 entitled “Array BioPharma’s ARRY-543 Shows Potential Clinical Benefit In Cancer Patients.”

 

4


 

This excerpt taken from the ARRY 8-K filed Apr 21, 2009.

EXHIBIT INDEX

 

Exhibit No.

 

 

 

 

 

99.1

 

Press release dated April 21, 2009 entitled “Array BioPharma’s ARRY-520 Demonstrates Significant Activity in Hematological and Taxane - Resistant Tumors.”

 

4


 

This excerpt taken from the ARRY 8-K filed Apr 20, 2009.

EXHIBIT INDEX

 

Exhibit No.

 

 

 

 

 

99.1

 

Press release dated April 19, 2009 entitled “Array BioPharma’s ARRY-614 Demonstrates Cytokine Inhibition and Anti-tumor Activity in Preclinical Models of Hematological Cancers.”

 

4


 

This excerpt taken from the ARRY 8-K filed Apr 8, 2009.

EXHIBIT INDEX

 

Exhibit No.

 

 

 

 

 

99.1

 

Press release dated April 8, 2009 entitled “Array BioPharma Initiates Clinical Trial in Type 2 Diabetic Patients.”

 

4


 

This excerpt taken from the ARRY 8-K filed Jan 13, 2009.

EXHIBIT INDEX

 

Exhibit
Number

 

Description

99.1

 

Press Release, dated January 9, 2009, entitled “Array BioPharma Accelerates Partnering Activities And Scales Back Discovery Research To Extend Available Capital”

 

4


This excerpt taken from the ARRY 8-K filed Dec 23, 2008.

EXHIBIT INDEX

 

Exhibit No.

 

 

 

 

 

99.1

 

Press release dated December 23, 2008 entitled “Array BioPharma Receives $40 million from Deerfield.”

 

4


 

This excerpt taken from the ARRY 8-K filed Dec 2, 2008.

EXHIBIT INDEX

 

Exhibit
Number

 

 

5.1

 

Opinion of Hogan & Hartson L.L.P

23.1

 

Consent of Hogan & Hartson L.L.P. (contained in Exhibit 5.1)

 

4


This excerpt taken from the ARRY 8-K filed Nov 7, 2008.

EXHIBIT INDEX

 

Exhibit 
Number

 

 

99.1

 

Press release dated November 7, 2008 entitled “Array BioPharma Inc. Files Shelf Registration Statement.”

 

4


This excerpt taken from the ARRY 8-K filed Oct 29, 2008.

EXHIBIT INDEX

 

Exhibit No.

 

 

 

 

 

99.1

 

Press release dated October 26, 2008 entitled “Array BioPharma’s Oral p38 Inhibitor Demonstrates Significant Analgesic Benefit and Systemic Anti-inflammatory Activity.”

 

4


This excerpt taken from the ARRY 8-K filed Sep 25, 2008.

EXHIBIT INDEX

 

Exhibit No.

 

 

 

 

 

99.1

 

Press release dated September 25, 2008 entitled “Array BioPharma Presents Positive Preclinical Data on its Glucokinase Activators in Type 2 Diabetes.”

 

4


This excerpt taken from the ARRY 8-K filed Jun 16, 2008.

EXHIBIT INDEX

 

Exhibit No.

 

 

 

 

 

99.1

 

Press release dated June 12, 2008 entitled “Array BioPharma Presents Additional Positive Phase I Results in Two Programs at the 2008 Annual European Congress of Rheumatology.”

 

4


This excerpt taken from the ARRY 8-K filed May 5, 2008.

EXHIBIT INDEX

 

Exhibit
Number

 

Description

 

 

 

4.1

*

Form of Warrant to Purchase Shares of Common Stock dated April 29, 2008 issued to Deerfield Private Design Fund, L.P. and Deerfield Private Design International, L.P.

 

 

 

10.1

*

Facility Agreement between Array BioPharma Inc. and Deerfield Private Design Fund, L.P. and Deerfield Private Design International, L.P. dated April 29, 2008

 

 

 

10.2

 

Security Agreement between Array BioPharma Inc. and Deerfield Private Design Fund, L.P. and Deerfield Private Design International, L.P. dated April 29, 2008

 

 

 

10.3

 

Registration Rights Agreement between Array BioPharma Inc. and Deerfield Private Design Fund, L.P. and Deerfield Private Design International, L.P. dated April 29, 2008

 

 

 

99.1

 

Press release entitled “Array BioPharma Receives $80 Million Funding Commitment,” dated May X, 2008

 


* Confidential Treatment of redacted portions has been applied for by the registrant.

 

5


This excerpt taken from the ARRY 8-K filed May 5, 2008.

EXHIBIT INDEX

 

Exhibit No.

 

 

 

 

 

99.1

 

Press release dated May 5, 2008 entitled “Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2008.”

 

4


This excerpt taken from the ARRY 8-K filed Mar 18, 2008.

EXHIBIT INDEX

 

Exhibit No.

 

 

 

 

 

99.1

 

Press release of Array BioPharma Inc. dated March 18, 2008 entitled “Array BioPharma Names Gary M. Clark, PH.D., Vice President, Biostatistics and Data Management.”

 

4


 

This excerpt taken from the ARRY 8-K filed Feb 4, 2008.

EXHIBIT INDEX

 

Exhibit No.

 

 

 

 

 

 

 

99.1

 

Press release dated February 4, 2008 entitled “Array BioPharma Reports Financial Results for the Second Quarter of Fiscal 2008.”

 

 


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki